Table 2 Clinical information of 71 lung squamous cell carcinoma and clusterin IHC intensity
From: Clusterin modulates transdifferentiation of non-small-cell lung cancer
Parameters | Number of cases | Clusterin IHC intensity | P-value |
|---|---|---|---|
Total case number | 71 | 1.0000 ± 0.0788 | |
Gender | |||
Male | 67 | 1.0150 ± 0.0829 | 0.4384 |
Female | 4 | 0.7481 ± 0.1090 | |
Age (yr) | |||
< =64 | 36 | 1.1520 ± 0.1308 | 0.0429* |
> 64 | 35 | 0.8303 ± 0.0810 | |
Tumor size (cm) | |||
< =3.5 | 37 | 0.9262 ± 0.1120 | 0.3821 |
> 3.5 | 34 | 1.0690 ± 0.1142 | |
Lymphnode status | |||
Positive | 36 | 1.0780 ± 0.1380 | 0.5850 |
Negative | 35 | 0.9860 ± 0.1028 | |
TNM stage | |||
I | 14 | 1.0420 ± 0.2009 | 0.8503 |
II | 39 | 1.0160 ± 0.1016 | |
III, IV | 18 | 0.9194 ± 0.1716 | |
Survival time (mon) | |||
< =60 | 36 | 1.0200 ± 0.1165 | 0.7968 |
> 60 | 35 | 0.9792 ± 0.1073 | |